Skip to main content
Thorax logoLink to Thorax
. 1989 Sep;44(9):766–767. doi: 10.1136/thx.44.9.766-b

Alveolitis associated with sulphamethoxypyridazine.

J C Porter, J S Friedland, F Wojnarowska, J G Ledingham
PMCID: PMC462071  PMID: 2588219

Full text

PDF
766

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Harvey J. E., Baldwin C. J., Wood P. J., Alberti K. G., Tattersfield A. E. Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) 1981 May;60(5):579–585. doi: 10.1042/cs0600579. [DOI] [PubMed] [Google Scholar]
  2. Kaumann A. J., Lemoine H. Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation. Naunyn Schmiedebergs Arch Pharmacol. 1987 Apr;335(4):403–411. doi: 10.1007/BF00165555. [DOI] [PubMed] [Google Scholar]
  3. Larsson S., Svedmyr N. Cumulative dose-response curves for comparison of oral bronchodilating drugs. A study of salbutamol and fenoterol. Ann Allergy. 1977 Nov;39(5):362–366. [PubMed] [Google Scholar]
  4. Pentikäinen P. J., Halinen M. O., Helin M. J. Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction. J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):1–6. [PubMed] [Google Scholar]
  5. Steinfort C. L., Wiggins J., Sheffield E. A., Keal E. E. Alveolitis associated with sulphamethoxypyridazine. Thorax. 1989 Apr;44(4):310–311. doi: 10.1136/thx.44.4.310. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES